Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis
Seasonal Allergic Conjunctivitis
About this trial
This is an interventional treatment trial for Seasonal Allergic Conjunctivitis focused on measuring Allergic, Conjunctivitis, Ketotifen, Histamine
Eligibility Criteria
Inclusion Criteria: Age 3 years or older. History of seasonal allergic conjunctivitis Presence of bilateral ocular itching/conjunctival hyperaemia (redness) at baseline: at least intensity degree 2 for itching, and at least intensity degree 4 for composite score of itching and conjunctival hyperaemia Exclusion Criteria: Other systemic/ophthalmic conditions Presence of any form of allergic conjunctivitis other than seasonal allergic conjunctivitis (e.g. perennial allergic conjunctivitis, vernal keratoconjunctivitis, atopic keratoconjunctivitis, giant papillary conjunctivitis). Active bacterial or viral conjunctivitis or history of ocular herpes. Presence or history of severe dry eye. Previous treatments Any systemic or ocular corticosteroids within two (2) weeks prior to randomization. Any systemic or ocular mast cell stabilizers within two (2) weeks prior to randomization. Any other ophthalmic medication within three (3) days prior to randomization. Other protocol-defined inclusion/exclusion criteria may apply
Sites / Locations
- Hospital of Shanghai Medical University